Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.

Kaira K, Tomizawa Y, Yoshino R, Yoshii A, Matsuura M, Iwasaki Y, Koga Y, Ono A, Nishioka M, Kamide Y, Hisada T, Ishizuka T, Shirai K, Ebara T, Saitoh J, Nakano T, Sunaga N.

Lung Cancer. 2013 Dec;82(3):449-54. doi: 10.1016/j.lungcan.2013.09.004. Epub 2013 Sep 19.

PMID:
24099666
2.

Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer.

Kaira K, Tomizawa Y, Yoshino R, Miura Y, Yoshii A, Iwasaki Y, Koga Y, Ono A, Hisada T, Minato K, Sato K, Kazama T, Ishihara S, Kohyama K, Fueki N, Saito R, Sunaga N.

Lung Cancer. 2013 Oct;82(1):103-8. doi: 10.1016/j.lungcan.2013.07.008. Epub 2013 Aug 5.

PMID:
23927884
3.

[Insulin allergy whose local/systemic reactions were reduced by desensitization with long-acting insulin analog, glargine].

Tuboi M, Tsuchiya T, Taguchi R, Tanaka Y, Iwasaki Y, Hashimoto K, Kakizaki S, Okada S, Shimizu H, Mori M.

Nihon Naika Gakkai Zasshi. 2010 Jan 10;99(1):133-5. Japanese. No abstract available.

PMID:
20196485
4.

Epigenetic inactivation of the thyroid hormone receptor beta1 gene at 3p24.2 in lung cancer.

Iwasaki Y, Sunaga N, Tomizawa Y, Imai H, Iijima H, Yanagitani N, Horiguchi K, Yamada M, Mori M.

Ann Surg Oncol. 2010 Aug;17(8):2222-8. doi: 10.1245/s10434-010-0956-9. Epub 2010 Feb 13.

PMID:
20155399
5.

A case of Legionella pneumonia linked to a hot spring facility in Gunma Prefecture, Japan.

Kurosawa H, Fujita M, Kobatake S, Kimura H, Ohshima M, Nagai A, Kaneko S, Iwasaki Y, Kozawa K.

Jpn J Infect Dis. 2010 Jan;63(1):78-9. No abstract available.

6.

[A case of neurosarcoidosis discovered in a patient complaining of chest pain].

Yanagitani N, Kotake M, Ishizuka T, Iwasaki Y, Sunaga N, Mori M.

Nihon Kokyuki Gakkai Zasshi. 2009 Dec;47(12):1087-92. Japanese.

PMID:
20058684
7.

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer.

Kaira K, Sunaga N, Tomizawa Y, Yanagitani N, Shimizu K, Imai H, Utsugi M, Iwasaki Y, Iijima H, Tsurumaki H, Yoshii A, Fueki N, Hisada T, Ishizuka T, Saito R, Mori M.

Lung Cancer. 2010 Jul;69(1):99-104. doi: 10.1016/j.lungcan.2009.09.012. Epub 2009 Oct 23.

PMID:
19853960
8.

Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.

Kaira K, Sunaga N, Yanagitani N, Imai H, Utsugi M, Iwasaki Y, Shimizu K, Iijima H, Tsurumaki H, Tomizawa Y, Hisada T, Ishizuka T, Saito R, Mori M.

Lung Cancer. 2010 May;68(2):253-7. doi: 10.1016/j.lungcan.2009.06.024. Epub 2009 Jul 23.

PMID:
19631403
9.

Membranous tracheoplasty using an azygous vein pedicle graft with roundabout-field intubation: a novel surgical technique.

Kamiyoshihara M, Ibe T, Iwasaki Y, Takise A, Takeyoshi I.

J Thorac Cardiovasc Surg. 2009 Jun;137(6):1560-2. doi: 10.1016/j.jtcvs.2008.03.045. Epub 2008 May 27. No abstract available.

10.

A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer.

Tomizawa Y, Ishihara S, Iijima H, Imai H, Sato K, Yatomi M, Iwasaki Y, Yamada H, Kobayashi G, Ishida E, Inoue T, Aoki H, Watanabe S, Kawashima O, Mori M, Saito R.

Am J Clin Oncol. 2007 Oct;30(5):498-502.

PMID:
17921710
11.

Obstructive sleep apnea syndrome accompanied by diabetes mellitus.

Nagai T, Imamura M, Iwasaki Y, Mori M.

J Med. 2003;34(1-6):23-30.

PMID:
17682308
12.

[A case of pulmonary hypertrophic osteoarthropathy associated with primary lung cancer in a young adult successfully treated with gefitinib].

Imai H, Tomizawa Y, Ishihara S, Sunaga N, Aoki H, Iijima H, Iwasaki Y, Watanabe S, Saito R, Mori M.

Nihon Kokyuki Gakkai Zasshi. 2007 Feb;45(2):189-93. Japanese.

PMID:
17352179
13.

[A case of multidrug-resistant non-small cell lung cancer responding to TS-1].

Imai H, Sunaga N, Kaira K, Ishihara S, Aoki H, Iijima H, Yanagitani N, Iwasaki Y, Tomizawa Y, Saito R, Mori M.

Gan To Kagaku Ryoho. 2007 Feb;34(2):221-4. Japanese.

PMID:
17301531
14.

"Crazy-paving" appearance in systemic lupus erythematosus.

Hisada T, Ishizuka T, Tomizawa Y, Iwasaki Y, Kawata T, Dobashi K, Mori M.

Intern Med. 2006;45(1):29-30. Epub 2006 Feb 1. No abstract available.

15.

Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers.

Iijima H, Tomizawa Y, Iwasaki Y, Sato K, Sunaga N, Dobashi K, Saito R, Nakajima T, Minna JD, Mori M.

Int J Cancer. 2006 Feb 15;118(4):797-801.

16.

Massive hemoptysis due to pulmonary tuberculosis.

Hisada T, Kayakabe K, Ishizuka T, Kuribayashi S, Kobayashi R, Iwasaki Y, Shimizu Y, Tomizawa Y, Tsukagoshi H, Dobashi K, Mori M.

Intern Med. 2005 Feb;44(2):156-7. No abstract available.

17.

Phase II study of weekly docetaxel and cisplatin in patients with non-small cell lung cancer.

Kaira K, Takise A, Minato K, Iwasaki Y, Ishihara S, Takei Y, Tsuchiya S, Saito R, Sato K, Mori M.

Anticancer Drugs. 2005 Apr;16(4):455-60.

PMID:
15746583
18.

Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.

Tomizawa Y, Iijima H, Nomoto T, Iwasaki Y, Otani Y, Tsuchiya S, Saito R, Dobashi K, Nakajima T, Mori M.

Lung Cancer. 2004 Dec;46(3):305-12.

PMID:
15541815

Supplemental Content

Loading ...
Support Center